Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 325Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12GALDERMA LABS LP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 8470788

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2024-04-22

blank

02

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 9233118

Drug Substance Claim :

Drug Product Claim :

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2034-03-13

blank

03

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 7550440

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2024-04-22

blank

04

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 8815816

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2024-04-22

blank

05

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 8093219

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2024-04-22

blank

06

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 8080530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2024-04-22

blank

07

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 8415311

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2024-04-22

blank

08

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 9089587

Drug Substance Claim :

Drug Product Claim :

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2034-03-13

blank

09

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 9233117

Drug Substance Claim :

Drug Product Claim :

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2034-03-13

blank

10

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

IVERMECTIN

US Patent Number : 9782425

Drug Substance Claim :

Drug Product Claim :

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2034-03-13

blank